PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-1177

  1. 4,525 Posts.
    lightbulb Created with Sketch. 110
    Hi DruStar,
    I can't find their phase2 results.
    Has CYP gone straight to P3 without P2?
    Also their P3 seems to be confined to Australia so they are not seeking FDA approval?
    Last edited by hercules007: 06/02/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.